Kristina Burow

Insider Reports History

Entity
Individual
Location
8755 W. Higgins Road, Suite 1025, Chicago, Illinois
Signature
/s/ Junlin Ho, Attorney-in-Fact for Kristina Burow
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristina Burow:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Neumora Therapeutics, Inc. Director, 10%+ Owner Common Stock 12.2 M $146 M $11.98 Jun 13, 2024 By ARCH Venture Fund X, L.P.
Neumora Therapeutics, Inc. Director, 10%+ Owner Common Stock 11.9 M $142 M $11.98 Jun 13, 2024 By ARCH Venture Fund X Overage, L.P.
Beam Therapeutics Inc. Director Common Stock 2.72 M $71.9 M $26.42 Jun 6, 2023 Indirect
Neumora Therapeutics, Inc. Director, 10%+ Owner Common Stock 4.13 M $49.5 M $11.98 Jun 13, 2024 By ARCH Venture Fund XII, L.P.
Neumora Therapeutics, Inc. Director, 10%+ Owner Common Stock 2.32 M $27.8 M $11.98 Jun 13, 2024 By ARCH Venture Fund VIII Overage, L.P.
Scholar Rock Holding Corp Director Common Stock 2.35 M $21.1 M $8.99 Jun 27, 2024 Indirect
Neumora Therapeutics, Inc. Director, 10%+ Owner Common Stock 1.39 M $16.6 M $11.98 Jun 13, 2024 By ARCH Venture Fund VII, L.P.
Beam Therapeutics Inc. Director Common Stock 26 K $687 K $26.42 Jun 6, 2023 Direct
Neumora Therapeutics, Inc. Director, 10%+ Owner Common Stock 47.7 K $572 K $11.98 Jun 13, 2024 Direct
Beam Therapeutics Inc. Director Stock Option (Right to Buy) 16.5 K $403 K $24.40 Jun 6, 2023 Direct
Scholar Rock Holding Corp Director Common Stock 18.8 K $169 K $8.99 Jun 27, 2024 Direct
Unity Biotechnology, Inc. Director Stock Option (Right to Buy) 25 K $69.3 K $2.77 Jun 24, 2021 Direct
Boundless Bio, Inc. Director, 10%+ Owner Common Stock 1.18 M Apr 2, 2024 Indirect
Gossamer Bio, Inc. Director Stock Option (Right to Buy) 35 K Jun 8, 2023 Direct
Neumora Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 28.6 K Jun 13, 2024 Direct
Boundless Bio, Inc. Director, 10%+ Owner Stock Option 26.4 K Mar 27, 2024 Direct
Scholar Rock Holding Corp Director Stock Option (Right to Buy) 18 K Jun 27, 2024 Direct
Metacrine, Inc. Director Stock Option (right to buy) 16.5 K May 24, 2021 Direct
Boundless Bio, Inc. Director, 10%+ Owner Series A Convertible Preferred Stock 0 Apr 2, 2024 Indirect
Boundless Bio, Inc. Director, 10%+ Owner Series B Convertible Preferred Stock 0 Apr 2, 2024 Indirect
Boundless Bio, Inc. Director, 10%+ Owner Series C Convertible Preferred Stock 0 Apr 2, 2024 Indirect
Neumora Therapeutics, Inc. Director, 10%+ Owner Series A-1 Preferred Stock 0 Sep 19, 2023 Direct
Neumora Therapeutics, Inc. Director, 10%+ Owner Series A-1 Preferred Stock 0 Sep 19, 2023 Indirect
Neumora Therapeutics, Inc. Director, 10%+ Owner Series A-2 Preferred Stock 0 Sep 19, 2023 Indirect
Neumora Therapeutics, Inc. Director, 10%+ Owner Series B Preferred Stock 0 Sep 19, 2023 Indirect

Insider Reports Filed by Kristina Burow

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRRK Scholar Rock Holding Corp Jun 27, 2024 2 $0 4 Jul 1, 2024 Director
NMRA Neumora Therapeutics, Inc. Jun 13, 2024 2 $0 4 Jun 14, 2024 Director, 10%+ Owner
BOLD Boundless Bio, Inc. Apr 2, 2024 12 $3.2 M 4 Apr 4, 2024 Director, 10%+ Owner
BOLD Boundless Bio, Inc. Mar 27, 2024 1 $0 4 Mar 29, 2024 Director, 10%+ Owner
BOLD Boundless Bio, Inc. Mar 27, 2024 0 $0 3 Mar 27, 2024 Director, 10%+ Owner
SRRK Scholar Rock Holding Corp Dec 21, 2023 2 $0 4 Dec 26, 2023 Director
NMRA Neumora Therapeutics, Inc. Dec 8, 2023 3 $0 4 Dec 12, 2023 Director, 10%+ Owner
NMRA Neumora Therapeutics, Inc. Nov 13, 2023 2 $412 K 4 Nov 15, 2023 Director, 10%+ Owner
NMRA Neumora Therapeutics, Inc. Nov 8, 2023 5 $1.54 M 4 Nov 13, 2023 Director, 10%+ Owner
NMRA Neumora Therapeutics, Inc. Nov 3, 2023 3 $1.1 M 4 Nov 7, 2023 Director, 10%+ Owner
NMRA Neumora Therapeutics, Inc. Sep 28, 2023 3 $1.05 M 4 Sep 29, 2023 Director, 10%+ Owner
NMRA Neumora Therapeutics, Inc. Sep 26, 2023 2 $700 K 4 Sep 27, 2023 Director, 10%+ Owner
NMRA Neumora Therapeutics, Inc. Sep 22, 2023 3 $1.13 M 4 Sep 25, 2023 Director, 10%+ Owner
NMRA Neumora Therapeutics, Inc. Sep 19, 2023 13 $25.5 M 4 Sep 20, 2023 Director, 10%+ Owner
NMRA Neumora Therapeutics, Inc. Sep 14, 2023 1 $0 4 Sep 18, 2023 Director
NMRA Neumora Therapeutics, Inc. Sep 14, 2023 0 $0 3 Sep 14, 2023 Director, 10%+ Owner
SRRK Scholar Rock Holding Corp Jun 21, 2023 1 $0 4 Jun 23, 2023 Director
GOSS Gossamer Bio, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
BEAM Beam Therapeutics Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
BEAM Beam Therapeutics Inc. Sep 1, 2022 1 $0 4 Sep 2, 2022 Director
GOSS Gossamer Bio, Inc. Jun 9, 2022 1 $0 4 Jul 15, 2022 Director
SRRK Scholar Rock Holding Corp May 26, 2022 1 $0 4 May 27, 2022 Director
BEAM Beam Therapeutics Inc. Jun 30, 2021 3 $0 4 Jul 2, 2021 Director
BEAM Beam Therapeutics Inc. Jun 25, 2021 6 $0 4 Jun 29, 2021 Director
UBX Unity Biotechnology, Inc. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director
BEAM Beam Therapeutics Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
GOSS Gossamer Bio, Inc. Jun 9, 2021 1 $0 4 Jun 10, 2021 Director
SRRK Scholar Rock Holding Corp May 27, 2021 1 $0 4 Jun 1, 2021 Director
MTCR Metacrine, Inc. May 24, 2021 1 $0 4 May 25, 2021 Director